




• I am not a Neurologist
• I am a very visual learner
Learning Objectives
• Understand the changing definition of TIA and how this impacts management
• Discuss the signs/symptoms of TIA vs. TIA-mimics, and strategies for 
distinguishing them 
• Categorize the major causes of TIA
• Discuss the approach to TIA evaluation in the PCP office
• Understand the value of risk stratification and the tools that can be used to 
achieve this in the outpatient setting
• Discuss the key aspects of TIA workup, diagnosis, and treatment
What we will NOT talk about
• Stroke and Stroke management
• In-depth dive into neurovascular anatomy
What is a TIA?
According to the AHA/ASA:
“A transient episode of neurological dysfunction caused by focal CNS 
(brain, spinal cord, or retina) ischemia, without acute infarction.”
Revision to the Definition
Previous definition was Time-based
• Symptoms < 24 hours
• Classical definition 
Time component removed by 2009 AHA/ASA definition
• “symptom duration is not a reliable predictor for the presence of infarction”
Current definition is Tissue-based
To Put it More Simply…
TIA can be thought of as a developing Stroke that 




3 Major Causes of TIA
1. Large Vessel Atherosclerosis




3. Small vessel disease
• Chronic HTN à thickened walls of penetrating arterioles à stenosis à ischemia
• Small vessel atherosclerosis
Signs and 
Symptoms
Ok maybe just a little bit of Neuroanatomy…
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Unilateral weakness and speech disturbance are 
the most common presenting symptoms of TIA.
Differential Diagnosis
• Complex Migraine / Migraine with aura
• Seizure Disorder
• Metabolic disturbance (ie: hypoglycemia)
• Presyncope/Syncope
• Peripheral neuropathy
• Intracranial hemorrhage, Brain tumor
• Multiple Sclerosis
• Transient Global Amnesia (TGA)
• Panic Attack
How to distinguish
• Focal vs. Non-focal
• Positive vs negative symptoms




• Other associated symptoms
• Patient demographics
How to distinguish
• Focal vs. Non-focal
• Positive vs negative symptoms
• Onset and progression (Sudden onset, maximal intensity)
• Duration (Variable, but vast majority < 1 hr)
• Recurrence (“shotgun”-like attacks over finite period of time)
• Precipitants (seemingly random attacks)
• Other associated symptoms (Less likely to have HA, N/V, LOC, incontinence, 
confusion)
• Patient demographics (Older, CVD risk factors)
History
• Symptoms of TIA 
• Symptoms of TIA mimics 
• Timing of symptom onset, resolution, and recurrence
• Any witnesses?












• Full Neuro exam
• Focal motor and/or sensory deficits
• Speech disturbance
• Ataxia
TIA is a neurological emergency
Risk of Future Stroke
• 4-20% will have Stroke within 90 days after TIA
• Front-loaded problem 
• Half will occur within 2 days
• Overall 2-day risk = 4-10%
• Recurrent symptoms, especially in the same vascular territory, are even more 
worrisome 
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Majority of patients (80-96%) will have a 
benign short-term course…
So how can we risk stratify patients 
presenting with TIA?
ABCD2 Score
• Estimates the risk of Stroke in a particular patient after a suspected TIA









• Low risk = 0-3
• 2-day Stroke risk: 1.0%
• Medium risk = 4-5
• 2-day Stroke risk: 4.5%
• High risk = 6-7
• 2-day Stroke risk: 8.1%
How good of a tool is it?
• Not great
• Validated in a largely older (> 65 yo) and white population in California and Oxford, UK
• Efficacy not well-established in follow-up studies
• Very few have demonstrated clear benefit when used as tool to determine hospitalization
• C-statistic = 0.62 - 0.83
• Ideal prediction produces a C-statistic of 1.0, whereas prediction no better than chance has a C-statistic of 0.5
2012 Meta-Analysis (Sanders et al.)
Predicted only minor changes from baseline post-TIA Stroke risk
“Our results caution against the use of the score alone to guide 
decisions for urgent investigation or hospital admission in TIA patients.”
ABCD2 Score for the PCP
• Suboptimally estimates risk of future Stroke in patients presenting with TIA
• AHA/ASA still recommends using it
• Helps to guide acuity and aggressiveness of management decisions
• New scores have been proposed which incorporate MRI findings (ie: ABCD2-I, CIP model)
• Validation studies needed
• Requirement for MRI lowers their generalizability
To admit, or not to admit, that is the question…
General Framework
• If within 72 hours of TIA onset and…
• ABCD2 Score 0-2 à complete outpatient workup within 48 hrs
• ABCD2 Score 0-2 and cannot complete outpatient workup within 48 hrs à
send to ED for workup and likely Obs
• ABCD2 Score 3+ à send to ED for workup and likely Admission
Benefits of Hospitalization
• Expedited TIA evaluation (labs, imaging)
• Early thrombolysis if symptoms recur
• Expedited initiation of secondary prevention measures







• TIA is a problem with the “plumbing” of the head and neck
• Workup should target the pipes and the fluid within those pipes

Pipes
Get imaging to evaluate:
Brain parenchyma à Intracranial vessels à Cervical vessels à Heart
AHA/ASA recommends neuroimaging within 
24-48 hours of symptom onset
Brain Parenchyma
Non-contrast MRI Brain w/ diffusion-weighted imaging (DWI)
Lansberg, Maarten G., et al. “Evolution of 
Apparent Diffusion Coefficient, Diffusion-
Weighted, and T2-Weighted Signal Intensity 
of Acute Stroke.” American Journal of 
Neuroradiology, American Journal of 
Neuroradiology, 1 Apr. 2001, 
www.ajnr.org/content/22/4/637. 
Intracranial Vessels
MRA/CTA of the Head and Neck
Cervical Vessels
MRA/CTA of the Head and Neck (anterior and posterior circulations) 
OR
Carotid Ultrasound (anterior circulation ONLY)
Heart
ECG +/- Cardiac Monitoring
Echo (with Bubble Study if < 60 yo)
Fluid within the Pipes
• Bloodwork
• POC glucose, BMP




• Other labs as clinically indicated 
• Thrombophilia workup à Protein C or S deficiency, Factor V Leiden, Antiphospholipid Syndrome, Sickle Cell
• RPR 
• CSF eval
Who might be a good candidate for a 
thrombophilia workup?
Favilla C, Heublein M, Brigham SK, Okamoto E, Watto MF. “#164 Stroke and TIA Deconstructed”. The Curbsiders Internal Medicine 
Podcast. https://thecurbsiders.com/episode-list August 5, 2019.
Treatment
• Early intervention is key! 
• EXPRESS trial (The Lancet, 2007)
• “Early initiation (<24 hrs) of existing treatments after TIA or minor stroke was associated with 
an 80% reduction in the risk of early recurrent stroke.”










• To prevent future Stroke following non-cardioembolic TIA
• Should be initiated as soon as possible
• In the acute setting: 
• ABCD2 score 0-3 à ASA 325mg
• ABCD2 score 4+ à DAPT
DAPT
• CHANCE + POINT trials
• Clopidogrel + ASA superior to ASA monotherapy in reducing 90-day Stroke risk
• DAPT initiated within 24 hours of symptom onset
• Mixed data on increased hemorrhage risk
• POINT + MATCH trials 
• Most benefit, least side effects with DAPT < 90 days
DAPT Recommendation
• Use when ABCD2 score 4 or greater
• Try to initiate within 24 hours
• Most common regimen:  
ASA + Clopidogrel x 21 days, followed by monotherapy indefinitely
• If ABCD2 score 0-3: 
• ASA 325mg acutely then antiplatelet monotherapy indefinitely
Chronic Secondary Prevention
For chronic secondary prevention: 
1. ASA 81mg alone
2. Clopidogrel (Plavix) alone




• Initiate even with brief runs of A-fib if no other cause identified
• DOAC vs Warfarin
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Lifestyle Modification
• Diet
• High intensity physical activity
• RRR 64% for future TIA/Stroke
•Weight loss
• Smoking cessation
• Decreased alcohol consumption
Blood Pressure Control
• Target BP < 140/90









• TIA and LDL > 100  à Start high intensity statin 
• Goal: > 50% reduction in LDL or LDL < 70
DM control
• Target A1c < 7 
• Not one particular agent that works best for Stroke prevention
Surgery
• Carotid Stenosis > 70% and acceptable perioperative risk à Carotid 
Endarterectomy
• Carotid Stenosis 50-69% and periop risk < 6% à Carotid Endarterectomy
• Carotid Stenosis < 50% à no surgical intervention indicated
• Carotid artery stenting as 2nd-line alternative
• EVA-3S, CREST trials
Case
64 yo F with PMH of DM2, A-fib on Xarelto, HTN, prior CVA, Gastritis, Lower GIB 
presenting with numbness and slurred speech that occurred 1 day prior. 
- R face and arm numbness. Sudden onset. A/w slurred speech per daughter 
report. Resolved completely within 5-10 minutes. No residual symptoms. Has 
not recurred. Denies LOC, confusion, HA, dizziness, vision loss. 
- Had similar episode 1 week prior
- VS: T 98.1F, HR 90, BP 129/72
- PE: Irregularly irregular. No carotid bruits. Strength 5/5, no facial droop. Speech 
slightly garbled, slow gait à both at baseline after prior Stroke per daughter
Summary
• TIA is a Tissue-based diagnosis, not Time-based
• Symptoms of TIA should be focal and transient 
• TIA should be considered a Neurological emergency
• Use the ABCD2 score to help guide management 
• Urgent evaluation/intervention can drastically reduce the risk of future Stroke
• Workup à evaluate the pipes and the fluid within them
• Target treatment to the etiology
• PCP can play a crucial role in both primary and secondary prevention
Resources
• MDCalc à ABCD2 score
• Curbsiders à Episode 164
• 2009 AHA/ASA Statement on TIA
• https://www.ahajournals.org/doi/pdf/10.1161/STROKEAHA.108.192218
Everyone loves a good algorithm! 
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